What's actually in a tirzepatide kit — and what the name gets wrong

Each Mounjaro (tirzepatide) KwikPen holds four once-weekly doses; you inject once a week until the pen is finished, then open the next one.
Tirzepatide is a dual GIP and GLP-1 receptor agonist, the only licensed weight-loss medicine in the UK that activates both gut-hormone pathways simultaneously.
The pen must be stored in the fridge at 2–8°C; always check the Patient Information Leaflet for the exact room-temperature window before travelling with it.
Tirzepatide is a Prescription-Only Medicine (POM); a GPhC-registered prescriber must assess your suitability before any supply can happen.

Search for a "tirzepatide kit" and you'll find a mix of test kits, home-use kits and starter packs — none of which is quite what the name implies. Tirzepatide, sold in the UK as Mounjaro, comes as a single pre-filled KwikPen containing four weekly doses; there is no separate kit to assemble. This is a prescription-only medicine requiring clinical assessment before any treatment begins, and understanding exactly what arrives (and how to use it safely) matters far more than the label people search for.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the pen contains, how it works, and what safe supply actually looks like

The myth: a "tirzepatide kit" is a box of separate parts you put together

This is the misconception driving most of these searches, and it's worth clearing up first. In the UK, tirzepatide is licensed and sold as Mounjaro, a pre-filled, ready-to-use KwikPen made by Eli Lilly. Nothing needs assembling. The pen arrives ready: you dial to your dose, pinch the skin at your injection site (abdomen, thigh or upper arm), hold the pen against it, and press. The needle is built in and covered. There is no vial, no syringe to fill, no cartridge to load.

Some searches for a "tirzepatide kit" actually mean a tirzepatide test kit, usually a blood test used to monitor metabolic markers before or during treatment. Others are looking for an at-home tirzepatide kit, which typically refers to the full supply process for a private patient: the prescription, the pen, and the aftercare support that arrives together. These are genuinely different things, and getting the distinction right helps you ask better questions.

One pen covers four weeks. UK strengths run from 2.5mg up to 15mg across six steps, with treatment always starting at 2.5mg, a dose designed to help your body adjust gradually before titration. The prescriber decides the pace of any increase based on your response and tolerability.

What tirzepatide actually does, and why the dual mechanism matters

Most GLP-1 medicines work on one receptor. Tirzepatide works on two: the GLP-1 receptor and the GIP receptor. Both are involved in appetite signalling, blood-sugar regulation and gastric emptying. Activating both simultaneously is the reason tirzepatide produces the trial outcomes it does. In SURMOUNT-1 (a 72-week study involving more than 2,500 adults with obesity) participants on the 15mg dose lost an average of around 20–21% of their body weight alongside a reduced-calorie diet and increased activity. That evidence underpins NICE's appraisal of tirzepatide (TA1026), published in December 2024.

The drug is licensed in the UK for weight management in adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. You can read the full picture on the tirzepatide overview page, or explore how it compares with other options on the weight-loss treatments overview.

It carries a Black Triangle (▼) designation from the MHRA, meaning it is subject to additional safety monitoring. That is routine for newer medicines and does not mean it is experimental; it means the regulator wants ongoing data as real-world use builds.

Storage, routine and what actually arrives in the post

Keep the pen in the fridge door, it fits neatly, stays at the right temperature, and you're unlikely to forget it. The NHS tirzepatide medicines page and the Patient Information Leaflet both confirm the 2–8°C requirement; the leaflet also states the exact period the pen can be kept at room temperature, which matters if you're travelling or away from home. Never quote a specific number of days from memory: check the leaflet every time, because it is the authoritative source.

When treatment is dispatched through a regulated pharmacy like ours at nume, the pen arrives in plain, unbranded packaging via tracked DPD delivery. No assembly, no clinic visit. For context on what private treatment costs across the market, the cost and pricing guide covers the figures honestly, including why the cheapest listing is often the wrong place to start for a prescription medicine.

Injection sites rotate: abdomen, thigh or upper arm each week. You do not need a carer or clinician to inject; the KwikPen mechanism is designed for self-administration. Our prescribers cover technique and site rotation at the consultation stage.

Why supply route matters as much as the pen itself

A KwikPen bought through an unverified seller is a different product in everything but appearance. The MHRA has warned publicly about counterfeit weight-loss pens that have contained insulin instead of tirzepatide, with serious consequences for the people who used them. The only safe route is a prescription from a registered prescriber, dispensed by a pharmacy you can verify on the GPhC register. You can check any online pharmacy's registration there in under a minute.

The question of whether tirzepatide and Mounjaro are the same thing comes up often; they are, Mounjaro is simply the brand name Eli Lilly uses for tirzepatide in the UK. If a seller offers something described as "tirzepatide" but not Mounjaro, and cannot account for its supply chain, that is a reason to stop and check, and you can find more detail on the specific formulation options on the tirzepatide L page. Sellers offering a prescription medicine without a prior clinical assessment are operating outside UK law.

If you are ready to find out whether tirzepatide is clinically suitable for you, the right starting point is our free consultation page. A GPhC-registered prescriber reads every submission the same day, a real clinician, not software.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions